Viatris Inc.
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets.
Drug Manufacturers - Specialty & Generic
US, Canonsburg [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about Viatris Inc.'s gradings, price targets and earnings estimates. None
| FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E | E | E | E | E | E | |||||||
| 2015 | - | 4.335 | - | 9,662 | - | 836 | - | 2,270 | - | 1,450 | - | 2,169 |
| 2016 | - | 4.739 | - | 10,987 | - | 5,719 | - | 2,910 | - | 797 | - | 2,877 |
| 2017 | - | 4.533 | - | 11,945 | - | 714 | - | 3,331 | - | 1,479 | - | 2,647 |
| 2018 | - | 4.636 | - | 11,392 | - | 350 | - | 3,026 | - | 920 | - | 2,516 |
| 2019 | - | 4.312 | - | 11,530 | - | 23 | - | 2,518 | - | 669 | - | 2,400 |
| 2020 | 0.0326 | 4.562 | 11,500 | 12,287 | 16 | 5,505 | 650 | 3,254 | 694 | 892 | 2,563 | 3,217 |
| 2021 | -1.1100 | 3.715 | 11,946 | 17,888 | -669 | -1,130 | 2,102 | 4,015 | -103 | -36 | 3,344 | 4,121 |
| 2022 | -1.0500 | 3.395 | 17,886 | 16,372 | -1,269 | 66 | 301 | 4,542 | 295 | 811 | 4,529 | 4,204 |
| 2023 | 1.7100 | 2.962 | 16,262 | 15,472 | 2,078 | -646 | 3,446 | 4,996 | 1,655 | 892 | 4,179 | 4,624 |
| 2024 | 0.0456 | 2.674 | 15,381 | 14,819 | 54 | 3,226 | 4,732 | 3,925 | 2,053 | 1,076 | 3,721 | 3,880 |
| 2025 | - | 2.688 | - | 14,426 | - | 3,213 | - | 3,820 | - | 1,047 | - | 3,777 |
| 2026 | - | 1.F11X/td> | - | 1.F11X/td> | - | 1.F11X/td> | - | 1.F111/td> | - | 1.F111 | - | 1.F111 |
| 2027 | - | 0.F12X/td> | - | 0.F12X/td> | - | 0.F12X/td> | - | 0.F121/td> | - | 0.F121 | - | 0.F121 |